Stimulating your mind, upgrading your body, and elevating your soul daily.
The first human trials of gene-editing technology CRISPR have just been approved. This post from Futurism sheds light on what RAC’s nod for the first human use of CRISPR entails.APPROVED!A proposal from doctors at the University of Pennsylvania for the first human use of CRISPR technology to treat cancer has just passed its first regulatory hurdle, getting the go-ahead from the ... Continue Reading
UVB light therapy on skin cells may dispatch soothing, inflammation-suppressing immune cells to the CNS. This could relieve MS symptoms, pain and inflammation. This post from Multiple Sclerosis Discovery Forum highlights the pilot study that found this and brought key open questions in the limelight.Ultraviolet B radiation (280–320 nm), like that in sunlight, suppresses ... Continue Reading
It's really happening. Scientists have found a way to a 'universal cancer vaccine' that persuades the body's immune system to attack tumors. Human trials begin. This post from ScienceAlert turns the spotlight on the early research that has demonstrated the results in mice.Scientists just took a big, "very positive" step towards developing what could be the first 'universal ... Continue Reading
An amazing study just discovered possible breakthrough news: 3 years after undergoing a stem cell treatment for MS, 91% of the patients are into remission. This post from ScienceAlert highlights how 86 percent of them have had no relapses, and 91 percent are showing no signs of MS development. A new stem cell treatment has sent most of the MS patients who tried it into ... Continue Reading
Studies show only 10-30% of published science articles are reproducible. What is happening? Why are our studies failing to hold up against scrutiny? This post from JoVE Blog questions the lack of reproducibility of science studies. Studies show a very low reproducibility for articles published in scientific journals, often as low as 10-30%. Here is a partial list:The ... Continue Reading
Send this to friend
